HilleVax, Inc (HLVX)
US Market

HilleVax, Inc (HLVX) Stock Price & Analysis


HLVX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$7.90 - $24.42
Previous Close$16.84
Average Volume (3M)67.80K
Market Cap
Enterprise Value$437.51M
Total Cash (Recent Filing)$260.54M
Total Debt (Recent Filing)$37.92M
Price to Earnings (P/E)-4.5
Jun 07, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.76
Shares Outstanding39,200,174
10 Day Avg. Volume145,983
30 Day Avg. Volume67,802
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)3.21
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-9.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit180.34
Enterprise Value/Ebitda-3.61
Price Target Upside72.21% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was HilleVax, Inc’s price range in the past 12 months?
HilleVax, Inc lowest stock price was $7.90 and its highest was $24.42 in the past 12 months.
    What is HilleVax, Inc’s market cap?
    Currently, no data Available
    When is HilleVax, Inc’s upcoming earnings report date?
    HilleVax, Inc’s upcoming earnings report date is Jun 07, 2023 which is in 10 days.
      How were HilleVax, Inc’s earnings last quarter?
      HilleVax, Inc released its earnings results on Mar 17, 2023. The company reported -$0.56 earnings per share for the quarter, beating the consensus estimate of -$1.452 by $0.892.
        Is HilleVax, Inc overvalued?
        According to Wall Street analysts HilleVax, Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does HilleVax, Inc pay dividends?
          HilleVax, Inc does not currently pay dividends.
          What is HilleVax, Inc’s EPS estimate?
          HilleVax, Inc’s EPS estimate is -$0.94.
            How many shares outstanding does HilleVax, Inc have?
            HilleVax, Inc has 39,200,172 shares outstanding.
              What happened to HilleVax, Inc’s price movement after its last earnings report?
              HilleVax, Inc reported an EPS of -$0.56 in its last earnings report, beating expectations of -$1.452. Following the earnings report the stock price went down -9.311%.
                Which hedge fund is a major shareholder of HilleVax, Inc?
                Among the largest hedge funds holding HilleVax, Inc’s share is Deerfield Management Company, LP. It holds HilleVax, Inc’s shares valued at 47M.


                  HilleVax, Inc Stock Smart Score

                  The HilleVax, Inc stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  HilleVax, Inc

                  HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.


                  Top 5 ETFs holding HLVX

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Schwab U.S. Broad Market ETF
                  iShares Russell 3000 ETF
                  Fidelity MSCI Health Care Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold HLVX. The ETFs are listed according to market value of HLVX within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Avidity Biosciences
                  Century Therapeutics
                  Tango Therapeutics
                  Bluebird Bio

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis